Literature DB >> 28916321

Analysis of resistance genes in pan-resistant Myroides odoratimimus clinical strain PR63039 using whole genome sequencing.

De-Song Ming1, Qing-Qing Chen2, Xiao-Tin Chen2.   

Abstract

To clarify the antibiotic resistance mechanisms of Myroides odoratimimus, pan-resistant M. odoratimimus strain PR63039 was isolated and its genome sequenced and analyzed. Antimicrobial susceptibility testing was conducted using the Kirby-Bauer disk diffusion method, and the Phoenix-100 Automated Microbiology System with a NMIC/ID-4 panel including aminoglycosides, β-lactams, polypeptides, quinolones, sulfonamides, chloramphenicols, and tetracyclines. Single-molecule real-time whole genome sequencing was conducted using the PacBio RSII system, and genome annotation was performed using RAST and IMG ER. To characterize the genome features, a number of databases and software programs, including GC-Profile, CG viewer, the VFDB database, ISfinder, RADB, CARD, ResFinder, and PHAST, were used. M. odoratimimus isolate PR63039 was resistant to almost all antibiotics tested, suggesting pan-drug resistance. The genome consisted of a 4,366,950-bp chromosome and a 90,798-bp plasmid (p63039), which contained a large number of resistance genes and virulence factors. The distribution of the resistance genes was distinctive, and a resistance region, designated MY63039-RR, was identified. RAST analysis indicated that 108 of the annotated genes were potentially involved in virulence, disease, and defense, all of which could be associated with resistance and pathogenicity. Prophage analysis also identified two incomplete prophages in the genome of M. odoratimimus PR63039. Multiple antibiotic-resistance genes were identified, including those associated with resistance to tetracycline (tetX), macrolides (ereB, cfrA, lasE), sulfonamides (sul2, sul3), β-lactams (blaMUS-1, blaTUS-1, blaSFB-1, blaSLB-1, blaOXA-209, blaOXA-347), and chloramphenicol (cat). Further, the presence of 18 antibiotic efflux pump-encoding resistance genes, including acrB, acrD, acrF, adeB, adeG, adeJ, amrB, ceoB, cmeB, mdsB, mexB, mexD, mexF, mtrD, smeE, mdtF, macB, likely accounts for the observed quinolone resistance of strain PR63039. To the best of our knowledge, this is the first report of the presence of the blaSFB-1, blaSLB-1, blaOXA-209, blaOXA-347, and tetX resistance genes in M. odoratimimus.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Myroides odoratimimus; Quinolones; Resistance; Whole genome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28916321     DOI: 10.1016/j.micpath.2017.09.012

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

1.  Myroides odoratimimus urinary tract infection in an immunocompromised patient: an emerging multidrug-resistant micro-organism.

Authors:  Giovanni Lorenzin; Giorgio Piccinelli; Lucrezia Carlassara; Francesco Scolari; Francesca Caccuri; Arnaldo Caruso; Maria Antonia De Francesco
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-06       Impact factor: 4.887

2.  Myroides spp. cellulitis and bacteremia: A case report.

Authors:  Amy Meyer; Harry Dang; William Roland
Journal:  IDCases       Date:  2019-09-07

3.  Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil.

Authors:  Marcelo Silva Folhas Damas; Roumayne Lopes Ferreira; Emeline Boni Campanini; Gabriela Guerrera Soares; Leslie Camelo Campos; Pedro Mendes Laprega; Andrea Soares da Costa; Caio César de Melo Freire; André Pitondo-Silva; Louise Teixeira Cerdeira; Anderson Ferreira da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 4.  Tetracycline-Inactivating Enzymes.

Authors:  Jana L Markley; Timothy A Wencewicz
Journal:  Front Microbiol       Date:  2018-05-30       Impact factor: 5.640

5.  Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1.

Authors:  Christopher Fröhlich; Vidar Sørum; Sandra Huber; Ørjan Samuelsen; Fanny Berglund; Erik Kristiansson; Stathis D Kotsakis; Nachiket P Marathe; D G Joakim Larsson; Hanna-Kirsti S Leiros
Journal:  J Antimicrob Chemother       Date:  2020-09-01       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.